ArticleJTO clinical and research reports2024

First Report of Response to Tarlatamab in a Patient With DLL3-Positive Pulmonary Carcinoid: Case Report.

Alissa J Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.